Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison

ABSTRACT BACKGROUND: The effect of weight loss (WL) on histopathological aspects of non-alcoholic fatty liver disease (NAFLD) may provide further insights into the dynamics of hepatic recovery after WL. OBJECTIVE: To analyze the effects of pre-operative WL on insulin resistance- and NAFLD-related histology in individuals undergoing bariatric surgery (BS) with or without pre-operative WL. DESIGN AND SETTING: A matched cross-sectional study was conducted at a public university hospital and a private clinic in Campinas, Brazil. METHODS: An analytical, observational, cross-sectional study was conducted using prospectively collected databases of individuals who underwent BS and liver biopsy at either a public tertiary university hospital (with pre-operative WL) or a private clinic (without pre-operative WL). Random electronic matching by gender, age, and body mass index (BMI) was performed and two paired groups of 24 individuals each were selected. RESULTS: Of the 48 participants, 75% were female. The mean age was 37.4 ± 9.6. The mean BMI was 38.9 ± 2.6 kg/m2. Fibrosis was the most common histopathological abnormality (91.7%). Glucose was significantly lower in the WL group (92 ± 19.1 versus 111.8 ± 35.4 mg/dL; P = 0.02). Significantly lower frequencies of macrovesicular steatosis (58.3% versus 95.8%; P = 0.004), microvesicular steatosis (12.5% versus 87.5%; P < 0.001), and portal inflammation (50% versus 87.5%; P = 0.011) were observed in the WL group. CONCLUSION: Pre-operative WL was significantly associated with lower frequencies of macro- and mi- crovesicular steatosis, portal inflammation, and lower glycemia, indicating an association between the recent trajectory of body weight and histological aspects of NAFLD.

[1]  É. Chaim,et al.  Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study , 2022, Sao Paulo medical journal = Revista paulista de medicina.

[2]  E. Cazzo,et al.  Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study , 2022, Obesity Surgery.

[3]  É. Chaim,et al.  SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. , 2022, Arquivos de gastroenterologia.

[4]  H. Healy,et al.  The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review , 2022, Obesity science & practice.

[5]  Dorothy D. Sears,et al.  WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Insulin and Insulin Resistance in Breast Cancer Survivors , 2021, Nutrients.

[6]  V. Kristiansen,et al.  Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies , 2021, Journal of clinical medicine.

[7]  F. Sacks,et al.  Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial , 2021, European Journal of Nutrition.

[8]  M. Imamura,et al.  Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients , 2021, Medicine.

[9]  B. Neuschwander‐Tetri,et al.  NAFLD: Reporting Histologic Findings in Clinical Practice , 2021, Hepatology.

[10]  É. Chaim,et al.  Non-Invasive Markers in Non-Alcoholic Fatty Liver Disease: Reliability Is Variable According to BMI Status , 2021, Obesity Surgery.

[11]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice. , 2020, Hepatology.

[12]  A. Kırık,et al.  Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease? , 2020, Acta gastro-enterologica Belgica.

[13]  H. Garg,et al.  Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan , 2020, Obesity Surgery.

[14]  K. Hachey,et al.  Gender disparities in weight loss surgery , 2020 .

[15]  A. Sultan,et al.  Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels , 2020, Journal of gastroenterology and hepatology.

[16]  É. Chaim,et al.  Influence of post-Roux-en-Y gastric bypass weight recidivism on insulin resistance: a 3-year follow-up. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[17]  A. Suzuki,et al.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps , 2019, Hepatology.

[18]  E. Muradova,et al.  Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[19]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[20]  J. Pareja,et al.  Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review , 2017, Sao Paulo medical journal = Revista paulista de medicina.

[21]  Robert V Farese,et al.  Lipid droplets and liver disease: from basic biology to clinical implications , 2017, Nature Reviews Gastroenterology &Hepatology.

[22]  J. Pareja,et al.  Influence of Insulin Resistance Status on the Development of Gallstones Following Roux-En-Y Gastric Bypass: a Prospective Cohort Study , 2016, Obesity Surgery.

[23]  P. Senthilnathan,et al.  The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[24]  S. Friedman,et al.  Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.

[25]  J. Lippincott-Schwartz,et al.  Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. , 2015, Developmental cell.

[26]  B. Ammori,et al.  Weight loss and metabolic outcomes of bariatric surgery in men versus women - A matched comparative observational cohort study. , 2014, European journal of internal medicine.

[27]  J. Pareja,et al.  Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation , 2014, Obesity Surgery.

[28]  N. Chalasani,et al.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) , 2013, Hepatology International.

[29]  N. Bhala,et al.  Epidemiology and natural history of patients with NAFLD. , 2013, Current pharmaceutical design.

[30]  Raj Vuppalanchi,et al.  Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. , 2011, Journal of hepatology.

[31]  Gustavo E. Guajardo-Salinas,et al.  Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Utility of FIBROspect II to Detect Liver Fibrosis in Morbidly Obese Hispano-American Patients Undergoing Gastric Bypass , 2010, Obesity surgery.

[32]  E. Jackvony,et al.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.

[33]  P. Schauer,et al.  Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort , 2009, Obesity.

[34]  B. Neuschwander‐Tetri,et al.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.

[35]  S. Jang,et al.  The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[37]  I. Leitman,et al.  Gender as a Deterministic Factor in Procedure Selection and Outcomes in Bariatric Surgery , 2021, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[38]  J. Pareja,et al.  Preoperative multidisciplinary program for bariatric surgery: a proposal for the Brazilian Public Health System. , 2017, Arquivos de gastroenterologia.